Virna M. Martín Giménez, Alejandra B. Camargo, Diego Kassuha and Walter Manucha* Pages 4681 - 4684 ( 4 )
Atherosclerosis provokes a continuous worsening of affected vessels causing a blood flow diminution with several complications and with clinical manifestations that generally appear in advanced phases of the illness. Hence, the conventional therapies are not enough because the atherosclerotic injuries are often irrevocable. For this reason, emerges the necessity to implement smart ways of drug supply and develop new therapeutic targets that decrease the advance atherosclerotic lesion. It results due to particular interest to use new tools for prevention, diagnosis, and treatment of this cardiovascular disease, thus concentrating our attention to accomplish better management on the immune system. Finally, this mini-review highlights the most recent knowledge about nanotechnology as a robust, novel and promissory therapeutic option applied to atherosclerotic pathology, nevertheless, we also alert for possible issues associated with their use.
atherosclerosis, treatment, diagnosis, nanotechnology, immune system, blood flow.
Instituto de Investigacion en Ciencias Quimicas, Facultad de Ciencias de la Alimentacion, Bioquimicas y Farmaceuticas, Universidad Catolica de Cuyo, San Juan, San Juan, IBAM, UNCuyo, Conicet, Facultad de Ciencias Agrarias, Chacras de Coria, Lujan, Mendoza, Instituto de Investigacion en Ciencias Quimicas, Facultad de Ciencias de la Alimentacion, Bioquimicas y Farmaceuticas, Universidad Catolica de Cuyo, San Juan, San Juan, Instituto de Medicina y Biologia Experimental de Cuyo, Consejo Nacional de Investigacion Cientifica y Tecnologica (Imbecu- Conicet)